Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral Primitive Neuroectodermal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01374451
What this trial is testing

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Who this might be right for
Islet Cell Tumor
Novartis Pharmaceuticals 160
Testing effectiveness (Phase 2)Study completedNCT00002560
What this trial is testing

Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00003203
What this trial is testing

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma
Children's Oncology Group 168
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Not applicableLooking for participantsNCT00898638
What this trial is testing

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Ended earlyNCT01505608
What this trial is testing

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Giselle Sholler 14
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490
What this trial is testing

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Who this might be right for
CholangiocarcinomaNeuroblastoma
Siriraj Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Early research (Phase 1)UnknownNCT05782959
What this trial is testing

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Who this might be right for
Neuroblastoma
Biocad 24
Not applicableLooking for participantsNCT04253015
What this trial is testing

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

Who this might be right for
Neuroblastoma
RECORDATI GROUP 125
Testing effectiveness (Phase 2)Study completedNCT00629889
What this trial is testing

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsSeizure
Dr Andrea Rossetti 52
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Large-scale testing (Phase 3)UnknownNCT00002516
What this trial is testing

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

Who this might be right for
Sarcoma
University Hospital Muenster
Early research (Phase 1)Study completedNCT01606878
What this trial is testing

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Who this might be right for
Childhood Solid NeoplasmRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Neuroblastoma
Children's Oncology Group 46
Early research (Phase 1)Study completedNCT00002748
What this trial is testing

Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 38
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Early research (Phase 1)Study completedNCT00946335
What this trial is testing

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more
National Cancer Institute (NCI) 31
Next Page